90 related articles for article (PubMed ID: 27428649)
21. Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer.
Xu JP; Branson JD; Lawrence R; Cocklin S
Bioorg Med Chem Lett; 2016 Feb; 26(3):824-828. PubMed ID: 26747394
[TBL] [Abstract][Full Text] [Related]
22. Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins.
Kobayakawa T; Yokoyama M; Tsuji K; Boku S; Kurakami M; Fujino M; Ishii T; Miura Y; Nishimura S; Shinohara K; Yamamoto K; Bolah P; Kotani O; Murakami T; Sato H; Tamamura H
Chem Pharm Bull (Tokyo); 2024; 72(1):41-47. PubMed ID: 38171903
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiviral evaluation of new N-acylhydrazones containing glycine residue.
Tian B; He M; Tan Z; Tang S; Hewlett I; Chen S; Jin Y; Yang M
Chem Biol Drug Des; 2011 Mar; 77(3):189-98. PubMed ID: 21306567
[TBL] [Abstract][Full Text] [Related]
24. Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.
Jia Q; Jiang X; Yu F; Qiu J; Kang X; Cai L; Li L; Shi W; Liu S; Jiang S; Liu K
Bioorg Med Chem Lett; 2012 Apr; 22(7):2393-5. PubMed ID: 22406118
[TBL] [Abstract][Full Text] [Related]
25. Design of antiviral stapled peptides containing a biphenyl cross-linker.
Muppidi A; Zhang H; Curreli F; Li N; Debnath AK; Lin Q
Bioorg Med Chem Lett; 2014 Apr; 24(7):1748-51. PubMed ID: 24613163
[TBL] [Abstract][Full Text] [Related]
26. Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library.
Wu G; Zalloum WA; Meuser ME; Jing L; Kang D; Chen CH; Tian Y; Zhang F; Cocklin S; Lee KH; Liu X; Zhan P
Eur J Med Chem; 2018 Oct; 158():478-492. PubMed ID: 30243152
[TBL] [Abstract][Full Text] [Related]
27. Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.
Tintori C; Selvaraj M; Badia R; Clotet B; Esté JA; Botta M
ChemMedChem; 2013 Mar; 8(3):475-83. PubMed ID: 23404750
[TBL] [Abstract][Full Text] [Related]
28. A Cell Internalizing Antibody Targeting Capsid Protein (p24) Inhibits the Replication of HIV-1 in T Cells Lines and PBMCs: A Proof of Concept Study.
Ali SA; Teow SY; Omar TC; Khoo AS; Choon TS; Yusoff NM
PLoS One; 2016; 11(1):e0145986. PubMed ID: 26741963
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers.
Turpin JA; Song Y; Inman JK; Huang M; Wallqvist A; Maynard A; Covell DG; Rice WG; Appella E
J Med Chem; 1999 Jan; 42(1):67-86. PubMed ID: 9888834
[TBL] [Abstract][Full Text] [Related]
30. Design of highly potent HIV fusion inhibitors based on artificial peptide sequences.
Shi W; Cai L; Lu L; Wang C; Wang K; Xu L; Zhang S; Han H; Jiang X; Zheng B; Jiang S; Liu K
Chem Commun (Camb); 2012 Dec; 48(94):11579-81. PubMed ID: 23093045
[TBL] [Abstract][Full Text] [Related]
31. Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.
Eckert DM; Kim PS
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11187-92. PubMed ID: 11572974
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors.
Kim J; Kwon J; Lee D; Jo S; Park DS; Choi J; Park E; Hwang JY; Ko Y; Choi I; Ju MK; Ahn J; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Ahn S; Sommer P; Liuzzi M; No Z; Lee J
Bioorg Med Chem Lett; 2013 Jan; 23(1):153-7. PubMed ID: 23206860
[TBL] [Abstract][Full Text] [Related]
33. Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.
Goudreau N; Lemke CT; Faucher AM; Grand-Maître C; Goulet S; Lacoste JE; Rancourt J; Malenfant E; Mercier JF; Titolo S; Mason SW
ACS Chem Biol; 2013 May; 8(5):1074-82. PubMed ID: 23496828
[TBL] [Abstract][Full Text] [Related]
34. Core chemotype diversification in the HIV-1 entry inhibitor class using field-based bioisosteric replacement.
Tuyishime M; Lawrence R; Cocklin S
Bioorg Med Chem Lett; 2016 Jan; 26(1):228-34. PubMed ID: 26531151
[TBL] [Abstract][Full Text] [Related]
35. Amphiphilic helical peptides containing two acridine moieties display picomolar affinity toward HIV-1 RRE and TAR.
Lee Y; Hyun S; Kim HJ; Yu J
Angew Chem Int Ed Engl; 2008; 47(1):134-7. PubMed ID: 17987636
[No Abstract] [Full Text] [Related]
36. An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors.
Sun L; Zhang X; Xu S; Huang T; Song S; Cherukupalli S; Zhan P; Liu X
Eur J Med Chem; 2021 May; 217():113380. PubMed ID: 33751981
[TBL] [Abstract][Full Text] [Related]
37. Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules.
Vernekar SKV; Sahani RL; Casey MC; Kankanala J; Wang L; Kirby KA; Du H; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
Viruses; 2020 Apr; 12(4):. PubMed ID: 32316297
[TBL] [Abstract][Full Text] [Related]
38. Microplate-based assay for identifying small molecules that bind a specific intersubunit interface within the assembled HIV-1 capsid.
Halambage UD; Wong JP; Melancon BJ; Lindsley CW; Aiken C
Antimicrob Agents Chemother; 2015 Sep; 59(9):5190-5. PubMed ID: 26077250
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of HIV-1 capsid protein assembly inhibitor (CAP-1) and its analogues based on a biomass approach.
Romashov LV; Ananikov VP
Org Biomol Chem; 2016 Dec; 14(45):10593-10598. PubMed ID: 27714265
[TBL] [Abstract][Full Text] [Related]
40. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
Neffe AT; Meyer B
Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
